Thomas Civik - Nov 18, 2021 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role: Director
Signature: /s/ Pamela Connealy, Attorney-in-Fact for Thomas Civik
Stock symbol: PYXS
Transactions as of: Nov 18, 2021
Transactions value $: $200,018
Form type: 4
Date filed: 11/19/2021, 12:21 PM
Previous filing: Nov 18, 2021
Next filing: Apr 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PYXS	Common Stock	Purchase	$200K	+15.7K		$12.74^*	15.7K	Nov 18, 2021	By Civik Family Trust	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.47 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F2	These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.47 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.